PTGS2 and neoplasm: Furthermore, the COX-2 inhibitory activity of 1–6 was also assessed, with the results attesting that these complexes can reduce tumour-related inflammation, despite the lack of correlation between COX-2 inhibition and in vitro cytotoxicity and lipophilicity.